TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.
The report is the result of a series of consultations with executive-level stakeholders from Ontario health organizations and industry, as well as representatives from government and other affiliate organizations.
Following a key recommendation in OBIO’s report, ‘Tackling the Anchor Company Challenge – OBIO Leadership Summit (2017),’ which highlighted the need for early adopter organizations in Ontario, the report provides a robust model for establishing, governing and supporting these organizations to best engage with innovators.
The report was launched at the Conference Board of Canada, Council on Innovation Procurement in Health Care meeting. OBIO CEO, Gail Garland, was joined by Arden Krystal, President and CEO of the Southlake Regional Health Centre, Jo-anne Marr, President & CEO of Markham Stouffville Hospital and Stefano Picone, Director of Finance of Conavi Medical.
“Today, it is clearer than ever that a model to support the early adoption of novel technologies is crucial if our health science industry is going to continue to commercialize life-saving products, create jobs and attract investment in Ontario. We are pleased to present the EAHN model as a way to achieve these benefits,” said Gail Garland, President and CEO, OBIO.
Overview of the Report:
- A network of early adopter health organizations (EAHNs) can facilitate the evaluation of and access to promising health science innovations that could benefit human health and wellbeing through their use in the Ontario healthcare system.
- The report presents a governance model for a collaborative ecosystem wherein industry and health organization end-users can work together to develop, test, refine, adopt, and deploy novel technologies for the health sector.
- Engagement with an EAHN will allow our growing health sciences industry to continue to innovate and assess the local market before they expand their sales to a larger global market. Investments in Ontario companies will become more attractive due to strong ties with the local market and foreign companies will be attracted to the favourable environment for innovation adoption in Ontario.
To read ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario,’ please click here.
The Ontario Bioscience Innovation Organization (OBIO®) founded in 2009, is a not-for-profit, membership-based organization engaged in strategy, programming, policy development and advocacy to further the commercialization of Ontario’s human health technologies positioning Ontario as a leader in the international marketplace. OBIO advances this goal through collaborative partnerships with industry, the investment community, academia, the health system and government.
For more information please visit www.obio.ca and follow OBIO on Twitter @OBIOscience.
